HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhenhai Zhang Selected Research

Adenocarcinoma

8/2022Corrigendum to "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1" [Canc. Lett. 385 (2017) 65-74].
1/2021[Corrigendum] Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma.
1/2018The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis.
10/2017Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma.
1/2017Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhenhai Zhang Research Topics

Disease

37Neoplasms (Cancer)
04/2024 - 02/2009
10Breast Neoplasms (Breast Cancer)
12/2023 - 01/2016
8Ulcerative Colitis
07/2023 - 02/2021
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017 - 07/2012
6Infections
08/2023 - 04/2013
6Inflammation (Inflammations)
01/2023 - 09/2014
6Hepatocellular Carcinoma (Hepatoma)
02/2022 - 04/2017
5Adenocarcinoma
08/2022 - 01/2017
4Lung Neoplasms (Lung Cancer)
01/2020 - 07/2012
3Carcinoma (Carcinomatosis)
10/2018 - 01/2013
2Constipation
12/2023 - 10/2023
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
12/2023 - 10/2023
2Fibrosis (Cirrhosis)
12/2023 - 09/2014
2Body Weight (Weight, Body)
10/2023 - 12/2021
2Wounds and Injuries (Trauma)
01/2023 - 08/2021
2Edema (Dropsy)
08/2022 - 01/2020
2Hypercholesterolemia
01/2021 - 01/2019
2Proteinuria
11/2020 - 01/2019
2Neoplasm Metastasis (Metastasis)
12/2019 - 01/2017
2Ovarian Neoplasms (Ovarian Cancer)
11/2019 - 04/2017
2IGA Glomerulonephritis (IGA Nephropathy)
01/2016 - 09/2014
2Aneurysm (Aneurysms)
03/2015 - 01/2014
1Rheumatoid Arthritis
12/2023
1Human Influenza (Influenza)
12/2023
1Hypersensitivity (Allergy)
10/2023
1Insulin Resistance
10/2023
1Bronchopulmonary Dysplasia
08/2023
1Malnutrition (Nutritional Deficiencies)
01/2023
1Hypoxia (Hypoxemia)
01/2023
1Weight Loss (Weight Reduction)
10/2022

Drug/Important Bio-Agent (IBA)

13MicellesIBA
07/2022 - 12/2013
9Paclitaxel (Taxol)FDA LinkGeneric
12/2023 - 12/2012
9Therapeutic UsesIBA
10/2023 - 11/2019
8Liposomes (Liposome)IBA
01/2020 - 09/2011
7Hyaluronic Acid (Hyaluronan)IBA
12/2023 - 12/2012
6tocophersolanIBA
12/2023 - 12/2013
6Proteins (Proteins, Gene)FDA Link
11/2020 - 04/2013
5Succinic Acid (Succinate)IBA
12/2023 - 01/2016
5HydrogelsIBA
01/2023 - 11/2020
5baohuoside IIBA
11/2017 - 07/2012
4ChitosanIBA
12/2022 - 11/2020
4GemcitabineFDA Link
08/2022 - 01/2017
4parthenolideIBA
06/2020 - 01/2018
4AntibodiesIBA
01/2020 - 05/2014
3VaccinesIBA
12/2023 - 04/2015
3Biomarkers (Surrogate Marker)IBA
08/2023 - 01/2016
3CyclodextrinsIBA
07/2023 - 07/2022
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 07/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2022 - 11/2019
3Betulinic AcidIBA
01/2020 - 02/2019
3LigandsIBA
11/2019 - 01/2017
3CholesterolIBA
01/2019 - 08/2009
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
11/2017 - 01/2016
3Cell-Penetrating PeptidesIBA
01/2015 - 12/2012
2AlginatesIBA
12/2023 - 10/2022
2honokiolIBA
08/2022 - 01/2020
2Simvastatin (Zocor)FDA LinkGeneric
08/2022 - 01/2017
2Cholic AcidIBA
02/2022 - 05/2021
2Immunoglobulin G (IgG)IBA
01/2022 - 12/2021
2Neutralizing AntibodiesIBA
01/2022 - 05/2014
2Immunoglobulins (Immunoglobulin)IBA
12/2021 - 04/2015
2jugloneIBA
08/2021 - 12/2016
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
05/2021 - 12/2012
2ProdrugsIBA
05/2021 - 01/2021
2Nanoparticle Drug Delivery SystemIBA
11/2020 - 01/2016
2FlavonoidsIBA
10/2019 - 01/2016
2ginsenoside M1IBA
01/2018 - 09/2016
2ErbB Receptors (EGF Receptor)IBA
04/2017 - 01/2014
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2016 - 01/2016
2celastrolIBA
01/2013 - 09/2011
1Glutamic Acid (Glutamate)FDA Link
12/2023
1Vitamin EFDA LinkGeneric
12/2023
1Protein CoronaIBA
12/2023
1Melitten (Melittin)IBA
12/2023
1CollagenIBA
12/2023
1AlbuminsIBA
12/2023
1SolutionsIBA
12/2023
1oxymatrineIBA
12/2023
1fenchoneIBA
10/2023
1Insulin (Novolin)FDA Link
10/2023
1Excipients (Suspending Agents)IBA
01/2023
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2023
1Glucose (Dextrose)FDA LinkGeneric
01/2023
1Immune Checkpoint InhibitorsIBA
12/2022
1ginsenoside Rg3IBA
12/2022
1Superoxide DismutaseIBA
10/2022
1Chlorogenic AcidIBA
10/2022
1AntioxidantsIBA
10/2022
1Peroxidase (Myeloperoxidase)IBA
10/2022
1polygalacturonic acid (pectic acid)IBA
09/2022
1Prostaglandins AIBA
09/2022
1Secretory Immunoglobulin A (SIgA)IBA
08/2022

Therapy/Procedure

14Therapeutics
04/2024 - 09/2010
3Immunotherapy
04/2024 - 01/2021
3Drug Therapy (Chemotherapy)
12/2023 - 01/2020
3Oral Administration
09/2022 - 12/2013
2Intravenous Injections
09/2022 - 01/2016
2Injections
11/2020 - 01/2017
1Intravenous Administration
04/2024
1Immunomodulation
12/2023